Genetic profiling of a chondroblastoma‐like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1‐FGFR1 gene fusion
- 8 May 2019
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 58 (10) , 731-736
Abstract
Conventional osteosarcoma is the most common primary malignancy of bone. This group of neoplasms is subclassified according to specific histological features, but hitherto there has been no correlation between subtype, treatment, and prognosis. By in‐depth genetic analyses of a chondroblastoma‐like osteosarcoma, we detect a genetic profile that is distinct from those previously reported in benign and malignant bone tumors. The overall genomic copy number profile was less complex than that typically associated with conventional osteosarcoma, and there was no activating point mutation in any of H3F3A, H3F3B, IDH1, IDH2, BRAF, or GNAS. Instead, we found a homozygous CDKN2A deletion, a DMD microdeletion and an FN1‐FGFR1 gene fusion. The latter alteration has been described in phosphaturic mesenchymal tumor. This tumor type shares some morphological features with chondroblastoma‐like osteosarcoma and we cannot rule out that the present case actually represents an FN1‐FGFR1 positive malignant phosphaturic mesenchymal tumor of bone without osteomalacia.Keywords
Funding Information
- Åke Wiberg Stiftelse
- Barncancerfonden
- Crafoordska Stiftelsen
- Kungliga Fysiografiska Sällskapet i Lund
- Medicinska Fakulteten, Lunds Universitet
- Vetenskapsrådet
This publication has 23 references indexed in Scilit:
- Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcomaNature Communications, 2017
- Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrationsOncotarget, 2015
- Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric OsteosarcomaCell Reports, 2014
- Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of boneNature Genetics, 2013
- R132C IDH1 Mutations Are Found in Spindle Cell Hemangiomas and Not in Other Vascular Tumors or MalformationsThe American Journal of Pathology, 2013
- Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndromeNature Genetics, 2011
- Clonal Evolution through Loss of Chromosomes and Subsequent Polyploidization in ChondrosarcomaPLOS ONE, 2011
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Recurrent BRAF mutations in Langerhans cell histiocytosisBlood, 2010
- Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral TumorsClinical Cancer Research, 2009